Novel imaging techniques for diffuse myocardial fibrosis

Future Cardiology

Volumn 7, Issue 5, 2011, Pages 643-650

  Sado, Daniel M ^a   Flett, Andrew S ^a   Moon, James C ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

diffuse myocardial fibrosis; imaging; noninvasive

Indexed keywords

ANGIOTENSIN II; BIOLOGICAL MARKER; COLLAGEN TYPE 1; GADOLINIUM; MATRIX METALLOPROTEINASE; TECHNETIUM 99M; TRANSFORMING GROWTH FACTOR BETA;

AORTA STENOSIS; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL EFFECTIVENESS; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; ELECTROCARDIOGRAM; HEALTH CARE COST; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; RELAXATION TIME; REVIEW; TRANSTHORACIC ECHOCARDIOGRAPHY;

CARDIOMYOPATHIES; CARDIOMYOPATHY, HYPERTROPHIC; CHEMOKINES; COLLAGEN; CONTRAST MEDIA; EXTRACELLULAR MATRIX; FIBROSIS; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY;

EID: 80053104011     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.11.45     Document Type: Review

References (69)

1. Rossi MA. Connective tissue skeleton in the normal left ventricle and in hypertensive left ventricular hypertrophy and chronic chagasic myocarditis. Med. Sci. Monit. 7, 820-832 (2001). (Pubitemid 32691767)
2. Libby P, Lee RT. Matrix matters. Circulation 102, 1874-1876 (2000).
3. Lindsay MM, Dunn FG. Biochemical evidence of myocardial fibrosis in veteran endurance athletes. Brit. J. Sports Med. 41, 447-452 (2007). (Pubitemid 47025805)
4. Kirsten HWJ, Tusscher T, Panfilov A. Influence of diffuse fibrosis on wave propagation in human ventricular tissue. Europace 9, vi38-vi45 (2007).
5. Mewton N, Liu CY, Croisille P et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 57, 890-903 (2011).
6. O'Hanlon R, Grasso A, Roughton M. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 56, 867-874 (2010).
7. Villari B, Campbell S, Hess O et al. Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J. Am. Coll. Cardiol. 22, 1477-1484 (1993). (Pubitemid 23316376)
8. St John Sutton MG, Lie J, Anderson K et al. Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. Br. Heart J. 44, 433-443 (1980). (Pubitemid 11250375)
9. Assomull RG, Prasad SK, Lyne J et al. Cardiovascular magnetic resonance, fibrosis and prognosis in dilated cardiomyopathy. J. Am. Coll. Cardiol. 48, 1977-1985 (2006). (Pubitemid 44738448)
10. Lewis JR, Mohanty SR. Non alcoholic fatty liver disease: a review and update. Dig. Dis. Sci. 55, 560-578 (2010).
11. Katsumoto TR, Whitfield ML, Connolly MK. The pathogenesis of systemic sclerosis. Ann. Rev. Pathol. 28, 509-537 (2011).
12. Verma S, Slutsky AS. Idiopathic pulmonary fibrosis - new insights. N. Engl J. Med. 356, 1370-1372 (2007).
13. Becker A, Heijmans C, Essed C. Chronic non-ischaemic congestive heart disease and endomyocardial biopsies. Worth the extra? Eur. Heart J. 12, 218-223 (1991).
14. Holzmann M, Nicko A, Kühl U et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11 year period. Circulation 118, 1722-1728 (2008).
15. Diez J. Mechanisms of cardiac fibrosis in hypertension. J. Clin. Hypertens. 9, 546-550 (2007).
16. Garzoni LR, Adesse D, Soares MJ, Rossi MI, Borojevic R, de Meirelles Mde N. Fibrosis and hypertrophy induced by Tryanosoma Cruzi in a three-dimensional cardiomyocyte-culture system. J. Infect. Dis. 197, 906-915 (2008). (Pubitemid 351417015)
17. Bernaba BN, Chan JB, Lai CK, Fishbein MC. Pathology of late-onset anthracycline cardiomyopathy. Cardiovasc. Pathol. 19, 308-311 (2010).
18. Meune C, Vignaux O, Kahan A, Allanore Y. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Arch. Cardiovasc. Dis. 103, 46-52 (2010).
19. Frangogiannis NG. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm. Res. 53, 585-595 (2004). (Pubitemid 40385316)
20. Lal H, Guleria RS, Foster DM et al. Integrins: novel therapeutic targets for cardiovascular diseases. Cardiovasc. Hematol. Agents Med. Chem. 5, 109-132 (2007). (Pubitemid 46681787)
21. Wynn TA. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199-210 (2008). (Pubitemid 351160157)
22. Watanabe T, Barker TA, Berk BC. Angiotensin 2 and the endothelium: diverse signals and effects. Hypertension 45, 163-169 (2005). (Pubitemid 40179951)
23. Bujak M, Frangogiannis NG. The role of TGF-b signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 74, 184-195 (2007). (Pubitemid 46517504)
24. Querejeta R, Lopez B, Gonzalez A et al. Increased collagen type 1 synthesis in patients with heart failure of hypertensive origin. Relation to myocardial fibrosis. Circulation 110, 1263-1268 (2004). (Pubitemid 39202343)
25. Swynghedauw B. Molecular mechanisms of myocardial remodelling. Physiol. Rev. 79, 215-262 (1999). (Pubitemid 29056953)
26. Shaub A. Unravelling the extracellular matrix. Nat. Cell. Biol. 1, 173-175 (1999). (Pubitemid 129502799)
27. Thomas CV, Coker ML, Zeliner JL, Handy JR, Crunbly AJ III, Spinale FG. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end stage dilated cardiomyopathy. Circulation 97, 1708-1715 (1998). (Pubitemid 28211420)
28. Martos R, Baugh J, Ledwidge M et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115, 888-895 (2007). (Pubitemid 46294729)
29. Lombardi R, Betocchi S, Losi A et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 108, 1455-1460 (2003). (Pubitemid 37176451)
30. Lopez B, Gonzalez A, Querejeta R, Diez J. The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease. J. Hypertens. 23, 1445-1451 (2005). (Pubitemid 41104811)
31. Pauschinger M, Knopf D, Petschauer S et al. Dilated cardiomyopathy is associated with significant changes in collagen type 1/3 ratio. Circulation 99, 2750-2756 (1999). (Pubitemid 29250020)
32. Lopez B, Gonzalez A, Diez J. Circulating biomarkers of collagen metabolism in cardiac diseases. Circulation 121, 1645-1654 (2010).
33. Kim RJ, Wu E, Rafael A et al. The use contrast enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N. Engl. J. Med. 343, 1445-1453 (2000).
34. Li A, Wong CS, Wong MK, Lee CM, Au Yeung MC. Acute adverse reactions to magnetic resonance contrast media-gadolinium chelates. Br. J. Radiol. 79, 368-371 (2006). (Pubitemid 43676338)
35. Kossoff G, Fry EK, Jellins J. Average velocity of ultrasound in the human female breast. J. Acoust. Soc. Am. 53, 1730-1736 (1973).
36. Picano E, Pelosi G, Marzilli M et al. In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans. Circulation 81, 58-64 (1990). (Pubitemid 20031767)
37. Di Bello V, Giorgi D, Viacava P et al. Severe aortic stenosis and myocardial function: diagnostic and prognostic usefulness of ultrasonic integrated backscatter analysis. Circulation 110, 849-855 (2004). (Pubitemid 39096014)
38. Mizuno R, Fujimoto S, Saito Y, Nakamnura S. Non-invasive quantification of myocardial fibrosis using combined tissue harmonic imaging of integrated backscatter analysis in dilated cardiomyopathy. Cardiology 108, 11-17 (2007). (Pubitemid 47014345)
39. Lythall DA, Bishop J, Greenbaum RA et al. Relationship between myocardial collagen and echo amplitude in non-fibrotic hearts. Eur. Heart J. 14, 344-350 (1993). (Pubitemid 23103416)
40. Losi MA, Betocchi S, Chinali M et al. Myocardial texture in hypertrophic cardiomyopathy. J. Am. Soc. Echocardiogr. 20, 1253-1259 (2007). (Pubitemid 350026742)
41. Losi MA, Memoli B, Contaldi C et al. Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis. Nephrol. Dial. Transplant. 25, 1950-1954 (2010).
42. Maceira AM, Joaquin J, Varo N, Beloqui O, Diez J. Ultrasonic backscatter and serum marker of cardiac fibrosis in hypertensives. Hypertension 39, 923-928 (2002). (Pubitemid 34437551)
43. Yamamoto Y, de Silva R, Rhodes CG et al. A new strategy for the assessment of viable myocardium and regional blood flow using 15O-water and dynamic positron emission tomography. Circulation 86, 167-178 (1992).
44. Knaapen P, Boellaard R, Gotte MJW et al. Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy. J. Nucl. Med. 45, 1299-1304 (2004). (Pubitemid 47618526)
45. Knaapen P, Götte MJ, Paulus WJ. Does myocardial fibrosis hinder contractile function and perfusion in idiopathic dilated cardiomyopathy? PET and MR imaging study. Radiology 240, 380-388 (2006). (Pubitemid 44098633)
46. Knappen P, Van Dockum WG, Bondarenko O et al. Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET. J. Nucl. Med. 46, 923-929 (2005). (Pubitemid 43733505)
47. Van den Borne SWM, Isobe S, Zandbergen R et al. Molecular imaging for efficacy of pharmacologic intervention in myocardial remodelling. J. Am. Coll. Cardiol. Cardiovasc. Imaging 2, 187-198 (2009).
48. Van den Borne SWM, Isobe S, Verjans JW et al. Molecular imaging of interstitial alterations in remodelling myocardium after myocardial infarction. J. Am. Coll. Cardiol. 52, 2017-2028 (2008).
49. Scholz TD, Fleagle FR, Burns TL, Skorton DJ. Nuclear magnetic resonance relaxometry of the normal heart: relationship between collagen content and relaxation times of the four chambers. Magn. Reson. Imaging 7, 643-648 (1989). (Pubitemid 20089422)
50. Moon JC, Prasad SK. Cardiovascular magnetic resonance and the evaluation of heart failure. Curr. Cardiol. Rep. 7, 39-44 (2005). (Pubitemid 40220509)
51. Sparrow P, Messroghli DR, Reid S, Ridgway JP, Bainbridge G, Sivanathan MU. Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study. Am. J. Roentgenol. 187, W630-W635 (2006).
52. Sueyoshi E, Sakamoto I, Uetani M. Contrast-enhanced myocardial inversion time at the null point for detection of left ventricular myocardial fibrosis in patients with dilated and hypertrophic cardiomyopathy: a pilot study. Am. J. Roentgenol. 194, W293-W298 (2010).
53. Han Y, Peters DC, Dokhan B, Manning WJ. Shorter difference between myocardium and blood optimal inversion time suggests diffuse fibrosis in dilated cardiomyopathy. J. Magn. Reson. Imaging 30, 967-972 (2009).
54. Jerosch-Herold M, Sheridan DC, Kushner JD et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 295, H1234-H1242 (2008).
55. Iles L, Pfluger H, Phrommintikul A et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J. Am. Coll. Cardiol. 52, 1547-1580 (2008).
56. Ugander M, Oki AB, Hsu LY et al. Myocardial extracellular volume imaging by CMR quantitatively characterizes myocardial infarction and subclinical myocardial fibrosis. J. Cardiovasc. Magn. Reson. 13(Suppl. 1), 200-201 (2011).
57. Broberg CS, Chugh SS, Conklin RT et al. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ. Cardiovasc. Imaging 3, 727-734 (2010).
58. Flacke SJ, Fischer SE, Lorenz CH. Measurement of the gadolinium dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology 218, 703-710 (2001). (Pubitemid 32172551)
59. Flett AS, Hayward MP, Ashworth MT et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122, 138-144 (2010).
60. Klein C, Nekolla SG, Balbach T et al. The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure. J. Magn. Reson. Imaging. 20(4), 588-593 (2004).
61. Sado DM, Flett AS, Cook CM et al. The quantification and role of diffuse myocardial fibrosis in familial dilated cardiomyopathy - an equilibrium contrast CMR study. J. Cardiovasc. Magn. Reson. 13(Suppl. 1), O108 (2011).
62. Flett AS, Sado DM, Quarta G et al. Beyond late gadolinium enhancement: the key role of diffuse myocardial fibrosis in severe aortic stenosis - an Equilibrium Contrast CMR study. J. Cardiovasc. Magn. Reson. 13(Suppl. 1), O39 (2011).
63. Piechnik SK, Ferreira VM, Dal'Armelina E et al. Shortened modified look-locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3T within a 9 heartbeat breathhold. J. Cardiovasc. Magn. Reson. 12, 69 (2010).
64. Schelbert EB, Testa SM, Meier CG et al. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J. Cardiovasc. Magn. Reson. 13, 16 (2011).
65. Farouc AJ, Wesssleder. Seeing within. Molecular imaging of the cardiovascular system. Circ. Res. 94, 433-445 (2004).
66. Bremer C, Tung CH, Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat. Med. 7, 743-748 (2001). (Pubitemid 32588033)
67. Wang J, Khoury DM, Thohan V, Torre- Amione G, Nagueh SF. Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures. Circulation 115, 1376-1383 (2007). (Pubitemid 46648373)
68. Götte MJ, Germans T, Rüssel IK et al. Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function. J. Am. Coll. Cardiol. 48, 2002-2011 (2006). (Pubitemid 44738446)
69. Marwick TH, Schwaiger M. The future of cardiovascular imaging in the diagnosis and management of heart failure, part 1: tasks and tools. Circ. Cardiovasc. Imaging 1, 58-69 (2008).